References

Medicines and Healthcare products Regulatory Agency. Citalopram and escitalopram: QT interval prolongation. 2014. www.gov.uk/drug-safety-update/citalopram-and-escitalopram-qt-interval-prolongation (accessed March 2025)
Medicines and Healthcare products Regulatory Agency. Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban. 2020. www.gov.uk/drug-safety-update/erythromycin-caution-required-due-to-cardiac-risks-qt-interval-prolongation-drug-interaction-with-rivaroxaban (accessed March 2025)
Medicines and Healthcare products Regulatory Agency. Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions. 2022. www.gov.uk/drug-safety-update/hydroxychloroquine-chloroquine-increased-risk-of-cardiovascular-events-when-used-with-macrolide-antibiotics-reminder-of-psychiatric-reactions (accessed March 2025)
Joint Formulary Committee. Dental Practitioners' Formulary. 2024. https://bnf.nice.org.uk/dental-practitioners-formulary/ (accessed March 2025)
Groot JAN, Ten Bokum L, van den Oever HLA Late presentation of torsades de pointes related to fluoxetine following a multiple drug overdose. J Intensive Care. 2018; 6 https://doi.org/10.1186/s40560-018-0329-1
Shah RR Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?. Br J Clin Pharmacol. 2013; 75:347-358 https://doi.org/10.1111/j.1365-2125.2012.04415.x
CredibleMeds. QT drugs list. www.crediblemeds.org (accessed March 2025)
Torsade de Pointes: overview, pathophysiology, etiology of torsade. 2024. https://emedicine.medscape.com/article/1950863-overview (accessed March 2025)
Specialist Pharmacy Service. Identifying risk factors for developing a long QT interval. 2023. www.sps.nhs.uk/articles/identifying-risk-factors-for-developing-a-long-qt-interval (accessed March 2025)
Wilde AAM, Amin AS, Postema PG Diagnosis, management and therapeutic strategies for congenital long QT syndrome. Heart. 2022; 108:332-338 https://doi.org/10.1136/heartjnl-2020-318259
Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G Prevalence of the congenital long-QT syndrome. Circulation. 2009; 120:1761-1767 https://doi.org/10.1161/CIRCULATIONAHA.109.863209
Joint Formulary Committee. Clarithromycin. 2025. https://bnf.nice.org.uk/drugs/clarithromycin/ (accessed March 2025)
Antimicrobial prescribing in dentistry: good practice guidelines. 2020. www.rcseng.ac.uk/-/media/files/rcs/fds/publications/fds-amp-2020.pdf (accessed March 2025)
Electronic Medicines Compendium. Summary of product characteristics: clarithromycin 500 mg film-coated tablets. 2024. www.medicines.org.uk/emc/product/7072/smpc (accessed March 2025)
Scottish Dental Clinical Effectiveness Programme. Antibiotic prophylaxis against infective endocarditis. Implementation advice. 2018. www.sdcep.org.uk/published-guidance/antibiotic-prophylaxis (accessed March 2025)
British National Formulary. Appendix 1. Interactions. Table 8. Drugs that prolong the QT interval. https://bnf.nice.org.uk/interactions/appendix-1-interactions/ (accessed March 2025)
Medicines and Healthcare products Regulatory Agency. Summary of product characteristics: Flagyl 400 mg tablets. 2025. https://products.mhra.gov.uk/ (accessed March 2025)
https://www.medicinescomplete.com/ (accessed March 2025)
British National Formulary. Metronidazole. 2025. https://bnf.nice.org.uk/drugs/metronidazole/ (accessed March 2025)
Finn D, Randall C, Field EA UK Dental Medicines Advisory Service: questions asked by dentists – part 5: prescribing for oromucosal diseases and dry mouth. Br Dent J. 2021; 231:689-695 https://doi.org/10.1038/s41415-021-3681-9
Electronic Medicines Compendium. Summary of product characteristics: Diflucan 150 capsules. 2024. www.medicines.org.uk/emc/product/1065/smpc (accessed March 2025)
Electronic Medicines Compendium. Summary of product characteristics: Daktarin oral gel. 2023. www.medicines.org.uk/emc/product/14746/smpc (accessed March 2025)
British National Formulary. Miconazole. 2025. https://bnf.nice.org.uk/drugs/miconazole/ (accessed March 2025)
Parsons G Mechanisms and management of drug-induced QT prolongation. Prescriber. 2022; 33:19-23 https://doi.org/10.1002/psb.2023

Drug-induced prolongation of the qt interval: implications for dental prescribing

From Volume 52, Issue 4, April 2025 | Pages 270-274

Authors

Rachel Botrugno

BDS, MFDS RCPS(Glasg), Specialist Registrar in Oral Medicine, Liverpool University Dental Hospital

Articles by Rachel Botrugno

Email Rachel Botrugno

E Anne Field

MDS, FDS RCS, DDSci

MDS, FDSRCS, DDSci, Consultant and Honorary Professor in Oral Medicine, Liverpool University Dental Hospital

Articles by E Anne Field

Christine Randall

BPharm MRPharmS

BPharm MRPharmS, Dental Medicines Advice Lead Pharmacist, Specialist Pharmacy Service, Liverpool

Articles by Christine Randall

Abstract

Prolongation of the QT interval, as measured on an electrocardiogram, can result in a ventricular arrhythmia known as torsade de pointes (TdP), which can be fatal. Individual drugs and interactions between drugs can pose a risk of QT interval prolongation. Some antimicrobial drugs on the Dental Practitioners' Formulary are associated with a risk of QT interval prolongation. An awareness of QT interval prolongation is critical for safe dental prescribing, particularly for patients with recognized risk factors, including cardiac disease and hepatic/renal impairment.

CPD/Clinical Relevance: For patients at risk of QT interval prolongation, certain antimicrobials that can be prescribed by general dental practitioners have the potential to cause life-threatening cardiac arrhythmias.

Article

Warnings have been issued over the past few years about drugs that are known to cause prolongation of the QT interval, which can result in a potentially life-threatening cardiac arrhythmia.1,2,3

Dentists treating NHS patients can prescribe from an approved list of drugs: the Dental Practitioners' Formulary (DPF).4 Some of the antimicrobial drugs on the DPF are associated with a risk of QT interval prolongation. This article has three aims:

The QT interval, as measured on an electrocardiogram (ECG), represents the time between the start of the Q wave to the end of the T wave. This corresponds to the start of ventricle depolarization to the end of ventricle repolarization (Figure 1). The QT interval varies with the patient's heart rate; as the heart rate increases, the QT interval shortens.

Register now to continue reading

Thank you for visiting Dental Update and reading some of our resources. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Up to 2 free articles per month
  • New content available